Logo image of NDLS

NOODLES & CO (NDLS) Stock Fundamental Analysis

USA - NASDAQ:NDLS - US65540B1052 - Common Stock

0.6417 USD
+0.01 (+0.93%)
Last: 10/3/2025, 8:00:01 PM
Fundamental Rating

1

NDLS gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 135 industry peers in the Hotels, Restaurants & Leisure industry. Both the profitability and financial health of NDLS have multiple concerns. NDLS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year NDLS has reported negative net income.
NDLS had a negative operating cash flow in the past year.
In the past 5 years NDLS reported 4 times negative net income.
NDLS had a positive operating cash flow in each of the past 5 years.
NDLS Yearly Net Income VS EBIT VS OCF VS FCFNDLS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M -60M

1.2 Ratios

NDLS has a Return On Assets of -14.62%. This is amonst the worse of the industry: NDLS underperforms 86.67% of its industry peers.
Industry RankSector Rank
ROA -14.62%
ROE N/A
ROIC N/A
ROA(3y)-4.93%
ROA(5y)-4.06%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NDLS Yearly ROA, ROE, ROICNDLS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 600

1.3 Margins

Looking at the Gross Margin, with a value of 22.88%, NDLS is doing worse than 82.96% of the companies in the same industry.
In the last couple of years the Gross Margin of NDLS has declined.
The Profit Margin and Operating Margin are not available for NDLS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.88%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.26%
GM growth 5Y-2.5%
NDLS Yearly Profit, Operating, Gross MarginsNDLS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

More info and screens

0

2. Health

2.1 Basic Checks

NDLS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NDLS has been increased compared to 1 year ago.
The number of shares outstanding for NDLS has been increased compared to 5 years ago.
NDLS has a worse debt/assets ratio than last year.
NDLS Yearly Shares OutstandingNDLS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
NDLS Yearly Total Debt VS Total AssetsNDLS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

NDLS has an Altman-Z score of 0.41. This is a bad value and indicates that NDLS is not financially healthy and even has some risk of bankruptcy.
NDLS has a worse Altman-Z score (0.41) than 77.78% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.41
ROIC/WACCN/A
WACC8.54%
NDLS Yearly LT Debt VS Equity VS FCFNDLS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 0.31 indicates that NDLS may have some problems paying its short term obligations.
NDLS's Current ratio of 0.31 is on the low side compared to the rest of the industry. NDLS is outperformed by 88.89% of its industry peers.
NDLS has a Quick Ratio of 0.31. This is a bad value and indicates that NDLS is not financially healthy enough and could expect problems in meeting its short term obligations.
NDLS has a Quick ratio of 0.16. This is amonst the worse of the industry: NDLS underperforms 97.04% of its industry peers.
Industry RankSector Rank
Current Ratio 0.31
Quick Ratio 0.16
NDLS Yearly Current Assets VS Current LiabilitesNDLS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

1

3. Growth

3.1 Past

NDLS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -180.95%.
The Revenue has decreased by -1.24% in the past year.
NDLS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.30% yearly.
EPS 1Y (TTM)-180.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-140%
Revenue 1Y (TTM)-1.24%
Revenue growth 3Y1.25%
Revenue growth 5Y1.3%
Sales Q2Q%-0.72%

3.2 Future

The Earnings Per Share is expected to grow by 6.18% on average over the next years.
NDLS is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -2.53% yearly.
EPS Next Y-19%
EPS Next 2Y6.18%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.13%
Revenue Next 2Y-2.53%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NDLS Yearly Revenue VS EstimatesNDLS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
NDLS Yearly EPS VS EstimatesNDLS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 0.4 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

NDLS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NDLS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NDLS Price Earnings VS Forward Price EarningsNDLS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NDLS indicates a somewhat cheap valuation: NDLS is cheaper than 79.26% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.24
NDLS Per share dataNDLS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.18%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NDLS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NOODLES & CO

NASDAQ:NDLS (10/3/2025, 8:00:01 PM)

0.6417

+0.01 (+0.93%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)08-13 2025-08-13/amc
Earnings (Next)10-30 2025-10-30
Inst Owners33.15%
Inst Owner Change-9.32%
Ins Owners6.48%
Ins Owner Change6%
Market Cap29.80M
Analysts82.5
Price Target2.04 (217.91%)
Short Float %2.66%
Short Ratio4.53
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-115.69%
Min EPS beat(2)-135.29%
Max EPS beat(2)-96.08%
EPS beat(4)0
Avg EPS beat(4)-89.55%
Min EPS beat(4)-135.29%
Max EPS beat(4)-19.24%
EPS beat(8)3
Avg EPS beat(8)-52.22%
EPS beat(12)5
Avg EPS beat(12)-42.79%
EPS beat(16)7
Avg EPS beat(16)-40.75%
Revenue beat(2)0
Avg Revenue beat(2)-3.7%
Min Revenue beat(2)-5.82%
Max Revenue beat(2)-1.59%
Revenue beat(4)0
Avg Revenue beat(4)-3.48%
Min Revenue beat(4)-5.82%
Max Revenue beat(4)-1.59%
Revenue beat(8)0
Avg Revenue beat(8)-2.97%
Revenue beat(12)0
Avg Revenue beat(12)-3.15%
Revenue beat(16)0
Avg Revenue beat(16)-3.16%
PT rev (1m)-20%
PT rev (3m)-29.41%
EPS NQ rev (1m)12.5%
EPS NQ rev (3m)-75%
EPS NY rev (1m)-0.96%
EPS NY rev (3m)-43.84%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.39%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.96%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.06
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 8.24
EPS(TTM)-0.59
EYN/A
EPS(NY)-0.39
Fwd EYN/A
FCF(TTM)-0.39
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS10.65
BVpS-0.66
TBVpS-0.83
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.62%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22.88%
FCFM N/A
ROA(3y)-4.93%
ROA(5y)-4.06%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.26%
GM growth 5Y-2.5%
F-Score3
Asset Turnover1.68
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 6.55
Cap/Depr 60.43%
Cap/Sales 3.49%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.31
Quick Ratio 0.16
Altman-Z 0.41
F-Score3
WACC8.54%
ROIC/WACCN/A
Cap/Depr(3y)146.29%
Cap/Depr(5y)115.44%
Cap/Sales(3y)7.61%
Cap/Sales(5y)5.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-180.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-140%
EPS Next Y-19%
EPS Next 2Y6.18%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.24%
Revenue growth 3Y1.25%
Revenue growth 5Y1.3%
Sales Q2Q%-0.72%
Revenue Next Year-1.13%
Revenue Next 2Y-2.53%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-3863.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year317.96%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y32.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-107.09%
OCF growth 3Y-40.65%
OCF growth 5Y-24.12%